Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP vs AP in Endometrial Cancer
NCT00052312Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Sep 2002
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 2, randomised, open-label trial of paclitaxel in endometrial cancer (EC) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: Progression-free survival at 18 months. Started Sep 2002; status: completed.
02
Drugs
paclitaxel
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00052312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00052312.